| __timestamp | Dr. Reddy's Laboratories Limited | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 205018000 |
| Thursday, January 1, 2015 | 62786000000 | 392709000 |
| Friday, January 1, 2016 | 62427000000 | 299694000 |
| Sunday, January 1, 2017 | 62453000000 | 397061000 |
| Monday, January 1, 2018 | 65724000000 | 434100000 |
| Tuesday, January 1, 2019 | 70421000000 | 782200000 |
| Wednesday, January 1, 2020 | 80591000000 | 1119900000 |
| Friday, January 1, 2021 | 86645000000 | 2437500000 |
| Saturday, January 1, 2022 | 100551000000 | 1560400000 |
| Sunday, January 1, 2023 | 42907000000 | 1815800000 |
| Monday, January 1, 2024 | 115557000000 | 1970500000 |
Data in motion
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited from 2014 to 2023. Over this period, Dr. Reddy's Laboratories consistently maintained a higher cost of revenue, peaking at approximately 115% more than Regeneron in 2024. Despite Regeneron's lower cost of revenue, it showed a remarkable growth trend, increasing its cost by over 780% from 2014 to 2023. Meanwhile, Dr. Reddy's experienced fluctuations, with a notable dip in 2023. This data highlights the contrasting strategies of these two industry leaders: Dr. Reddy's with its expansive operations and Regeneron with its focused growth. Missing data for Regeneron in 2024 suggests a potential shift or strategic change, warranting further observation.
Regeneron Pharmaceuticals, Inc. vs Insmed Incorporated: Efficiency in Cost of Revenue Explored
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Regeneron Pharmaceuticals, Inc. and Dyne Therapeutics, Inc.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored